HeyJaredJonathan Swichar
- Indexed articles, last 90 days
- 4
- Latest publication
- Sep 22, 2026
- Outlet visibility, for Mondaq
- Top 500K sites
- Earliest in this view
- Aug 7, 2026
Latest articles
Pharmacies Sue PBM For Reimbursements Set Below The NADAC Payment Floor (opens the original)
Read excerpt
The pharmacies contend that each claim, in which ESI reimbursed the pharmacy below the published NADAC amount, constitutes a separate violation of Act 990. On September 15, 2026, a dozen independent pharmacies in Arkansas filed a lawsuit against Express Scripts Inc. (ESI), a pharmacy benefit manager (PBM), alleging that it reimbursed the pharmacies for prescription claims below Arkansas’ required reimbursement floor as measured by the government benchmark, the National Average Drug Acquisition C
Most-Favored-Nation Drug Pricing Agreements Expanded To Nine Additional Pharmaceutical Manufacturers (opens the original)
Read excerpt
On August 31, 2026, the Trump administration announced it has reached most-favored-nation (MFN) drug pricing agreements with nine additional pharmaceutical manufacturers. According to the White House, the latest agreements bring the total number of manufacturers that have entered into MFN arrangements with the administration to 26, collectively representing approximately 89 percent of the branded prescription drug market. The announcement represents another significant step in the administration
D.C. Circuit Upholds Key Medicare Drug Pricing Rules, But Leaves An Opening To Challenge Aspects Of The Medicare Drug Price Negotiation Program (opens the original)
Read excerpt
The IRA has fundamentally changed the Medicare prescription drug market by authorizing CMS to negotiate prices for certain high-expenditure, single-source drugs. On August 18, 2026, the U.S. Court of Appeals for the D.C. Circuit issued an important decision in Teva Pharmaceuticals USA, Inc. v. Kennedy, a challenge to the Centers for Medicare and Medicaid Services’ (CMS) implementation of the Medicare Drug Price Negotiation Program established by the Inflation Reduction Act of 2022 (IRA). The IRA
New York Halts New Medicaid Provider Enrollments For Six Months (opens the original)
Read excerpt
The moratorium is similar to federal moratoriums implemented by CMS earlier this year. In direct response to a Centers for Medicare and Medicaid Services (CMS) directive issued to all state governors on April 23, 2026, requiring all states to revalidate every enrolled Medicaid provider within 24 months, New York state Medicaid Director Amir Bassiri announced on July 30, 2026, an immediate moratorium of at least six months on new Medicaid provider enrollments, including processing affected change
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For Mondaq, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.